Author:
Herrera David,Serrano Jorge,Roldán Silvia,Alonso Bettina,Sanz Mariano
Abstract
Abstract
Objectives
The objective of the present narrative review was to evaluate the evidence of a possible association between periodontitis and COVID-19, and its biological plausibility, using as models the potential associations with cardiovascular diseases, diabetes, and some respiratory diseases.
Methods
A recent systematic review was used as main reference to explore the associations of periodontitis with different respiratory diseases, including COVID-19, following two focussed questions: a PECOS question, aimed to explore epidemiological evidence, and a PICOS question, designed to explore the evidence derived from intervention studies. In addition to that evidence, other relevant scientific documents, including consensus papers, were carefully selected and appraised.
Findings
Convincing evidence was found to support the association of periodontitis and cardiovascular diseases, diabetes, and some respiratory diseases. The biological plausibility behind those associations is based on four factors: (1) bacteraemia of oral bacteria and periodontal pathogens, (2) increased systemic inflammation, (3) common genetic factors, and (4) common environmental risk factors. Limited initial evidence is available to support an association between periodontitis and COVID-19 complications. Among the proposed factors to explain the suggested association, a combination of the previously mentioned factors, plus additional factors related with SARS-CoV-2 characteristics and pathogenicity, has been suggested.
Conclusions
Initial evidence suggests that periodontitis may be associated with a more severe COVID-19 and with a higher risk of death due to COVID-19.
Clinical relevance
Due to the possible association between periodontitis and an increased severity for COVID-19, additional efforts should be made to improve oral and periodontal health, including the promotion of oral healthy habits, such as oral hygiene.
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. World Health Organization (2020) Transmission of SARS-CoV-2: implications for infection prevention precautions. World Health Organization, Scientific Brief.
2. World Health Organization (2022) COVID-19 Weekly Epidemiological Update Edition 122 (December 14th, 2022). World Health Organization.
3. Sachs JD, Karim SSA, Aknin L, Allen J, Brosbol K, Colombo F, Barron GC, Espinosa MF, Gaspar V, Gaviria A, Haines A, Hotez PJ, Koundouri P, Bascunan FL, Lee JK, Pate MA, Ramos G, Reddy KS, Serageldin I et al (2022) The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet 400:1224–1280. https://doi.org/10.1016/S0140-6736(22)01585-9
4. Abufares HI, Oyoun Alsoud L, Alqudah MAY, Shara M, Soares NC, Alzoubi KH, El-Huneidi W, Bustanji Y, Soliman SSM, Semreen MH (2022) COVID-19 vaccines, effectiveness, and immune responses. Int J Mol Sci 23:15415. https://doi.org/10.3390/ijms232315415
5. Mostaghimi D, Valdez CN, Larson HT, Kalinich CC, Iwasaki A (2022) Prevention of host-to-host transmission by SARS-CoV-2 vaccines. Lancet Infect Dis 22:e52–e58. https://doi.org/10.1016/S1473-3099(21)00472-2
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献